Cited by

• Latin American Consensus on management of residual cardiometabolic risk. A consensus paper prepared by the Latin American Academy for the Study of Lipids and Cardiometabolic Risk (ALALIP) endorsed by the Inter-American Society of Cardiology (IASC), the International Atherosclerosis Society (IAS), and the Pan-American College of Endothelium (PACE).

  Ponte-Negretti CI, Wyss FS, Piskorz D, Santos RD, Villar R, Lorenzatti A, López-Jaramillo P, Toth PP, Amaro AJJ, Rodrigo AK, Lanas F, Urina-Triana M, Lara J, Valdés TO, Gomez-Mancebo JR, Bryce A, Cobos S L, Puente-Barragan A, Ullauri-Solórzano VE, Medina-Palomino FA, Lozada AF, Duran M, Berrospi P, Miranda D, Badimon JJ, González JJR, Libby P. Ponte-Negretti CI, et al. Arch Cardiol Mex. 2022 Jan 3;92(1):99-112. doi: 10.24875/ACM.21000005. Arch Cardiol Mex. 2022. PMID: 34187049 Free PMC article.
• Insights into genetics, human biology and disease gleaned from family based genomic studies.

  Posey JE, O'Donnell-Luria AH, Chong JX, Harel T, Jhangiani SN, Coban Akdemir ZH, Buyske S, Pehlivan D, Carvalho CMB, Baxter S, Sobreira N, Liu P, Wu N, Rosenfeld JA, Kumar S, Avramopoulos D, White JJ, Doheny KF, Witmer PD, Boehm C, Sutton VR, Muzny DM, Boerwinkle E, Günel M, Nickerson DA, Mane S, MacArthur DG, Gibbs RA, Hamosh A, Lifton RP, Matise TC, Rehm HL, Gerstein M, Bamshad MJ, Valle D, Lupski JR; Centers for Mendelian Genomics. Posey JE, et al. Genet Med. 2019 Apr;21(4):798-812. doi: 10.1038/s41436-018-0408-7. Epub 2019 Jan 18. Genet Med. 2019. PMID: 30655598 Free PMC article. Review.
• Hypertriglyceridemia and atherosclerosis.

  Peng J, Luo F, Ruan G, Peng R, Li X. Peng J, et al. Lipids Health Dis. 2017 Dec 6;16(1):233. doi: 10.1186/s12944-017-0625-0. Lipids Health Dis. 2017. PMID: 29212549 Free PMC article. Review.
• Origin and therapy for hypertriglyceridaemia in type 2 diabetes.

  Pang J, Chan DC, Watts GF. Pang J, et al. World J Diabetes. 2014 Apr 15;5(2):165-75. doi: 10.4239/wjd.v5.i2.165. World J Diabetes. 2014. PMID: 24748930 Free PMC article. Review.
• Potassium selenocyanoacetate reduces the blood triacylglycerol and atherosclerotic plaques in high-fat-dieted mice.

  Liu S, Fang F, Fan G. Liu S, et al. Cardiovasc Diagn Ther. 2019 Dec;9(6):561-567. doi: 10.21037/cdt.2019.12.05. Cardiovasc Diagn Ther. 2019. PMID: 32038945 Free PMC article.